Chemoinformaics analysis of 7,8-didehydro-3- methoxy-17-methyl-6-methylene morphinan
| Molecular Weight | 281.399 | nRot | 1 |
| Heavy Atom Molecular Weight | 258.215 | nRig | 21 |
| Exact Molecular Weight | 281.178 | nRing | 4 |
| Solubility: LogS | -3.455 | nHRing | 1 |
| Solubility: LogP | 3.392 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 48.9682 |
| nHD | 0 | BPOL | 26.5198 |
| QED | 0.783 |
| Synth | 4.687 |
| Natural Product Likeliness | 1.604 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.876 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.687 |
| MDCK | 0.0000207 |
| BBB | 0.998 |
| PPB | 0.545176 |
| VDSS | 3.203 |
| FU | 0.392585 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.529 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.968 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.275 |
| CYP2d6-inh | 0.974 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.818 |
| CL | 15.4 |
| T12 | 0.182 |
| hERG | 0.593 |
| Ames | 0.075 |
| ROA | 0.457 |
| SkinSen | 0.924 |
| Carcinogencity | 0.686 |
| EI | 0.01 |
| Respiratory | 0.967 |
| NR-Aromatase | 0.022 |
| Antiviral | No |
| Prediction | 0.672158 |